Literature DB >> 12005105

Human adrenocortical cell xenotransplantation: model of cotransplantation of human adrenocortical cells and 3T3 cells in scid mice to form vascularized functional tissue and prevent adrenal insufficiency.

Michael Thomas1, Xiangdong Wang, Peter J Hornsby.   

Abstract

To establish an experimental model for replacement of endocrine organ function by xenotransplantation, human adrenocortical cells from postnatal donors were transplanted beneath the kidney capsule of adrenalectomized scidmice together with mitomycin C-treated 3T3 cells that secrete FGF. Adrenocortical cells from seven donors, male and female, ranging from 6-50 years of age, were used. 12 of 13 animals survived > 16 days following surgery. After 50 days they were sacrified to allow assessment of the histology and ultrastructure of tissue formed from the transplanted cells. Only 1 of 23 adrenalectomized sham-operated animals survived > 16 days. In all surviving animals, vascularized adrenocortical tissue formed at the site of transplantation. Cortisol, the normal human glucocorticoid, was present in the plasma of these animals, replacing corticosterone, the mouse glucocorticoid. Some animals, but not most, had measurable aldosterone. The tissue formed from the transplanted cells showed histological and ultrastructural features of normal adrenal cortex. Mitochondria had tubulo-vesicular cristae and there were prominent microvilli between cells. Tissues had a well-developed vasculature, sometimes with large sinusoidal vessels. Proliferation in the transplant tissues was very low. These results show that tissue formed from transplanted human adrenocortical cells is able to replace the essential functions of the adrenal gland in scid mice. This demonstrates that transplanted human endocrine cells can functionally replace a surgically removed endocrine organ in a host animal.

Entities:  

Mesh:

Year:  2002        PMID: 12005105     DOI: 10.1046/j.0908-665x.2001.00138.x

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  10 in total

1.  Transplantation of adrenocortical cells.

Authors:  P J Hornsby
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  Fibroblast stimulation of blood vessel development and cancer cell invasion in a subrenal capsule xenograft model: stress-induced premature senescence does not increase effect.

Authors:  Dan Liu; Peter J Hornsby
Journal:  Neoplasia       Date:  2007-05       Impact factor: 5.715

3.  Optimizing orthotopic cell transplantation in the mouse adrenal gland.

Authors:  Cibele C Cardoso; Stefan R Bornstein; Peter J Hornsby
Journal:  Cell Transplant       Date:  2010-06-03       Impact factor: 4.064

4.  Glucocorticoid replacement therapies: past, present and future.

Authors:  Su-Yi Liew; Scott A Akker; Leonardo Guasti; James F H Pittaway
Journal:  Curr Opin Endocr Metab Res       Date:  2019-09-04

Review 5.  Improving cell therapy--experiments using transplanted telomerase-immortalized cells in immunodeficient mice.

Authors:  Qin Huang; Meizhen Chen; Sitai Liang; Victor Acha; Dan Liu; Furong Yuan; Christina L Hawks; Peter J Hornsby
Journal:  Mech Ageing Dev       Date:  2006-11-22       Impact factor: 5.432

6.  Transplantation of adrenal cortical progenitor cells enriched by Nile red.

Authors:  James C Y Dunn; Yinting Chu; Harry H Qin; Tatiana Zupekan
Journal:  J Surg Res       Date:  2009-05-14       Impact factor: 2.192

7.  The minimal set of genetic alterations required for conversion of primary human fibroblasts to cancer cells in the subrenal capsule assay.

Authors:  Beicheng Sun; Meizhen Chen; Christina L Hawks; Olivia M Pereira-Smith; Peter J Hornsby
Journal:  Neoplasia       Date:  2005-06       Impact factor: 5.715

Review 8.  New methods for investigating experimental human adrenal tumorigenesis.

Authors:  Cibele C Cardoso; Stefan R Bornstein; Peter J Hornsby
Journal:  Mol Cell Endocrinol       Date:  2008-11-13       Impact factor: 4.102

9.  Fibroblasts from Werner syndrome patients: cancer cells derived by experimental introduction of oncogenes maintain malignant properties despite entering crisis.

Authors:  Furong Yuan; Meizhen Chen; Peter J Hornsby
Journal:  Oncol Rep       Date:  2010-02       Impact factor: 3.906

Review 10.  New directions for the treatment of adrenal insufficiency.

Authors:  Gerard Ruiz-Babot; Irene Hadjidemetriou; Peter James King; Leonardo Guasti
Journal:  Front Endocrinol (Lausanne)       Date:  2015-05-06       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.